Why is Medtech right for DTx and vice versa

Pharma has been the main stakeholder collaborating with DTx companies so far; however, beyond these partnerships, there seems to be an untapped potential in Medtech companies as they seem to be more aligned with DTx startups due to its focus on devices, connectivity and interoperability. DTx could help Medtech in building new means to engage with patients to both improve efficiencies and gather meaningful data.

How should DTx companies think about Medtech as the appropriate partner and vice versa? Which are the types of Medtech verticals/ clinical divisions more suitable for DTx (e.g dialysis machines, surgery, etc)? In this meeting, we will discuss the unexplored opportunities in Medtech-DTx partnerships and the viable business models for these to partner.